Antiplatelet and anticoagulant therapy in elective percutaneous coronary intervention
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1745-6215
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Antiplatelet and anticoagulant therapy in elective percutaneous coronary intervention ; volume:2 ; number:3 ; day:31 ; month:5 ; year:2001 ; pages:1-12 ; date:6.2001
Trials ; 2, Heft 3 (31.5.2001), 1-12, 6.2001
- Creator
-
ten Berg, Jurriën M.
- Contributor
-
Plokker, HW Thijs
Verheugt, Freek WA
SpringerLink (Online service)
- DOI
-
10.1186/cvm-2-3-129
- URN
-
urn:nbn:de:1111-2016050214972
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:59 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- ten Berg, Jurriën M.
- Plokker, HW Thijs
- Verheugt, Freek WA
- SpringerLink (Online service)
Other Objects (12)
Antiplatelet strategy during ad-hoc percutaneous coronary intervention in elective patients: how aggressive should we be?
Perioperative Guidelines on Antiplatelet and Anticoagulant Agents: 2022 Update
AFM investigation of APAC (antiplatelet and anticoagulant heparin proteoglycan)
When and How to Combine Antiplatelet and Anticoagulant Drugs?
Novel Aspects of Antiplatelet Drug Therapy in Patients Undergoing Percutaneous Coronary Intervention : Antiplatelet Therapy in Patients Undergoing PCI
Duration of dual antiplatelet therapy following percutaneous coronary intervention on re-hospitalization for acute coronary syndrome
Prognostic implications of unrecognized myocardial infarction before elective percutaneous coronary intervention
Priapism: A very rare complication of dual antiplatelet therapy after percutaneous coronary intervention
Biological Control of Combined Treatment by Antiplatelet and Anticoagulant Drugs
Clinical implementation of rapid CYP2C19 genotyping to guide antiplatelet therapy after percutaneous coronary intervention
Stroke of antiplatelet and anticoagulant therapy in patients with coronary artery disease: a meta-analysis of randomized controlled trials
Meta-analysis of Unguided De-escalation of Dual Antiplatelet Therapy in Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention
Antiplatelet strategy during ad-hoc percutaneous coronary intervention in elective patients: how aggressive should we be?
Perioperative Guidelines on Antiplatelet and Anticoagulant Agents: 2022 Update
AFM investigation of APAC (antiplatelet and anticoagulant heparin proteoglycan)
When and How to Combine Antiplatelet and Anticoagulant Drugs?
Novel Aspects of Antiplatelet Drug Therapy in Patients Undergoing Percutaneous Coronary Intervention : Antiplatelet Therapy in Patients Undergoing PCI
Duration of dual antiplatelet therapy following percutaneous coronary intervention on re-hospitalization for acute coronary syndrome
Prognostic implications of unrecognized myocardial infarction before elective percutaneous coronary intervention
Priapism: A very rare complication of dual antiplatelet therapy after percutaneous coronary intervention
Biological Control of Combined Treatment by Antiplatelet and Anticoagulant Drugs
Clinical implementation of rapid CYP2C19 genotyping to guide antiplatelet therapy after percutaneous coronary intervention
Stroke of antiplatelet and anticoagulant therapy in patients with coronary artery disease: a meta-analysis of randomized controlled trials
Meta-analysis of Unguided De-escalation of Dual Antiplatelet Therapy in Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention
Antiplatelet strategy during ad-hoc percutaneous coronary intervention in elective patients: how aggressive should we be?
Perioperative Guidelines on Antiplatelet and Anticoagulant Agents: 2022 Update
AFM investigation of APAC (antiplatelet and anticoagulant heparin proteoglycan)
When and How to Combine Antiplatelet and Anticoagulant Drugs?
Novel Aspects of Antiplatelet Drug Therapy in Patients Undergoing Percutaneous Coronary Intervention : Antiplatelet Therapy in Patients Undergoing PCI
Duration of dual antiplatelet therapy following percutaneous coronary intervention on re-hospitalization for acute coronary syndrome
Prognostic implications of unrecognized myocardial infarction before elective percutaneous coronary intervention
Priapism: A very rare complication of dual antiplatelet therapy after percutaneous coronary intervention
Biological Control of Combined Treatment by Antiplatelet and Anticoagulant Drugs
Clinical implementation of rapid CYP2C19 genotyping to guide antiplatelet therapy after percutaneous coronary intervention
Stroke of antiplatelet and anticoagulant therapy in patients with coronary artery disease: a meta-analysis of randomized controlled trials